Market capitalization | €79.96m |
Enterprise Value | €108.31m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 1.96 |
P/S ratio (TTM) P/S ratio | 1.44 |
P/B ratio (TTM) P/B ratio | 4.34 |
Revenue growth (TTM) Revenue growth | 3.66% |
Revenue (TTM) Revenue | €55.37m |
As a Free StocksGuide user, you can view scores for all 6,879 stocks worldwide.
4 Analysts have issued a BRAIN Biotech forecast:
4 Analysts have issued a BRAIN Biotech forecast:
Mar '24 |
+/-
%
|
||
Revenue | 55 55 |
4%
4%
|
|
Gross Profit | 3.90 3.90 |
205%
205%
|
|
EBITDA | -1.66 -1.66 |
63%
63%
|
EBIT (Operating Income) EBIT | -6.44 -6.44 |
29%
29%
|
Net Profit | -8.05 -8.05 |
8%
8%
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
B.R.A.I.N. Biotechnology Research & Information Network AG is a technology company, which engages in the development and commercialization of bioactives, natural compounds, and proprietary enzymes. It operates through the BioScience and BioIndustrial segments. The BioScience segment works on enzymes and performance microorganisms; and collaborates with industrial partners. The BioIndustrial segment deals with the bioproduct and cosmetics businesses. The company was founded by Ulrich Putsch, Holger Zinke, Gabriele Sachse, and Hans-Günter Gassen in 1993 and is headquartered in Zwingenberg, Germany.
Head office | Germany |
CEO | Adriaan Moelker |
Employees | 309 |
Founded | 1993 |
Website | www.brain-biotech.de |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.